Correlation Between HLB Pharmaceutical and InnoTherapy
Can any of the company-specific risk be diversified away by investing in both HLB Pharmaceutical and InnoTherapy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLB Pharmaceutical and InnoTherapy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLB Pharmaceutical Co and InnoTherapy, you can compare the effects of market volatilities on HLB Pharmaceutical and InnoTherapy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLB Pharmaceutical with a short position of InnoTherapy. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLB Pharmaceutical and InnoTherapy.
Diversification Opportunities for HLB Pharmaceutical and InnoTherapy
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between HLB and InnoTherapy is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding HLB Pharmaceutical Co and InnoTherapy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InnoTherapy and HLB Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLB Pharmaceutical Co are associated (or correlated) with InnoTherapy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InnoTherapy has no effect on the direction of HLB Pharmaceutical i.e., HLB Pharmaceutical and InnoTherapy go up and down completely randomly.
Pair Corralation between HLB Pharmaceutical and InnoTherapy
Assuming the 90 days trading horizon HLB Pharmaceutical Co is expected to under-perform the InnoTherapy. But the stock apears to be less risky and, when comparing its historical volatility, HLB Pharmaceutical Co is 1.04 times less risky than InnoTherapy. The stock trades about -0.02 of its potential returns per unit of risk. The InnoTherapy is currently generating about 0.42 of returns per unit of risk over similar time horizon. If you would invest 835,000 in InnoTherapy on November 8, 2024 and sell it today you would earn a total of 177,000 from holding InnoTherapy or generate 21.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HLB Pharmaceutical Co vs. InnoTherapy
Performance |
| Timeline |
| HLB Pharmaceutical |
| InnoTherapy |
HLB Pharmaceutical and InnoTherapy Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HLB Pharmaceutical and InnoTherapy
The main advantage of trading using opposite HLB Pharmaceutical and InnoTherapy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLB Pharmaceutical position performs unexpectedly, InnoTherapy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InnoTherapy will offset losses from the drop in InnoTherapy's long position.| HLB Pharmaceutical vs. Moadata Co | HLB Pharmaceutical vs. Cuckoo Homesys Co | HLB Pharmaceutical vs. Mirai Semiconductors Co | HLB Pharmaceutical vs. Koryo Credit Information |
| InnoTherapy vs. Kolon Life Science | InnoTherapy vs. JETEMA Co | InnoTherapy vs. Aminologics CoLtd | InnoTherapy vs. Daihan Pharmaceutical CoLtd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |